mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0002 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |